학술논문

The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cells
Document Type
Article
Source
In: Breast Cancer Research and Treatment. (Breast Cancer Research and Treatment, September 2011, 129(2):387-400)
Subject
Language
English
ISSN
01676806
15737217